{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:56:57Z","timestamp":1783601817549,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04279-2","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T13:53:00Z","timestamp":1753797180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Place of dexamethasone implant as an adjunctive treatment in Coats\u2019 disease: a retrospective single-center study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ozlem","family":"Ural Fatihoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziya","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Kavukcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Osman","family":"Saatci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"5","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0002-9394(00)00883-7","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001;131(5):561\u201371.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/24741264211018957","volume":"6","author":"WA Alsakran","year":"2022","unstructured":"Alsakran WA, Nowilaty SR, Ghazi NG, Alzahrani Y, AlZaid A, Mura M, et al. Adjunctive intravitreal triamcinolone acetonide for exudative retinal detachment in coats disease. J Vitreoretin Dis. 2022;6(1):54\u201362.","journal-title":"J Vitreoretin Dis"},{"issue":"1","key":"4279_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3928\/1542-8877-20000101-19","volume":"31","author":"NF Tekin","year":"2000","unstructured":"Tekin NF, Saatci AO, Kavuk\u00e7u S. Vascular tortuosity and Coats\u2019-like retinal changes in facioscapulohumeral muscular dystrophy. Ophthalmic Surg Lasers. 2000;31(1):82\u20133.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"6","key":"4279_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.oret.2024.11.017","volume":"9","author":"ASH Tsai","year":"2025","unstructured":"Tsai ASH, Wang CT, Lee TC, Nagiel A, Matsunaga K, Harper CA 3rd, et al. Clinical characteristics and treatment outcomes in unilateral coats disease: a global collaborative study. Ophthalmol Retina. 2025;9(6):570\u20139.","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4103\/ijo.IJO_841_19","volume":"67","author":"M Sen","year":"2019","unstructured":"Sen M, Shields CL, Honavar SG, Shields JA. Coats disease: an overview of classification, management and outcomes. Indian J Ophthalmol. 2019;67(6):763\u201371.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"4279_CR6","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/hmg\/8.11.2031","volume":"8","author":"GC Black","year":"1999","unstructured":"Black GC, Perveen R, Bonshek R, Cahill M, Clayton-Smith J, Lloyd IC, et al. Coats\u2019 disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet. 1999;8(11):2031\u20135.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4279_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/humu.20093","volume":"24","author":"AI den Hollander","year":"2004","unstructured":"den Hollander AI, Davis J, van der Velde-Visser SD, Zonneveld MN, Pierrottet CO, Koenekoop RK, et al. CRB1 mutation spectrum in inherited retinal dystrophies. Hum Mutat. 2004;24(5):355\u201369.","journal-title":"Hum Mutat"},{"issue":"1","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/bjo.2010.183616","volume":"95","author":"EH Sohn","year":"2011","unstructured":"Sohn EH, Michaelides M, Bird AC, Roberts CJ, Moore AT, Smyth D, et al. Novel mutation in PANK2 associated with retinal telangiectasis. Br J Ophthalmol. 2011;95(1):149\u201350.","journal-title":"Br J Ophthalmol"},{"key":"4279_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1746-1596-1-24","volume":"1","author":"BF Fernandes","year":"2006","unstructured":"Fernandes BF, Odashiro AN, Maloney S, Zajdenweber ME, Lopes AG, Burnier MN Jr. Clinical-histopathological correlation in a case of Coats\u2019 disease. Diagn Pathol. 2006;1:24.","journal-title":"Diagn Pathol"},{"issue":"3","key":"4279_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/aos.13971","volume":"97","author":"J Zhang","year":"2019","unstructured":"Zhang J, Jiang C, Ruan L, Huang X. Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats\u2019 disease. Acta Ophthalmol. 2019;97(3):319\u201324.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"4279_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12886-020-01421-0","volume":"20","author":"T Liang","year":"2020","unstructured":"Liang T, Xu Y, Zhu X, Zhang X, Li J, Zhao P. Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease. BMC Ophthalmol. 2020;20(1):178.","journal-title":"BMC Ophthalmol"},{"key":"4279_CR12","unstructured":"Melih P, Aylin Y, BERK AT, \u00d6zer E, Saatci AO, Ziya A. Coats\u2019 Hastal\u0131\u011f\u0131 ve Tedavi Yakla\u015f\u0131mlar\u0131. Retina-Vitreus 2017;26(4):301\u20136"},{"issue":"5","key":"4279_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of coats disease: the 2000 proctor lecture. Am J Ophthalmol. 2001;131(5):572\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4279_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10792-019-01095-8","volume":"39","author":"X Yang","year":"2019","unstructured":"Yang X, Wang C, Su G. Recent advances in the diagnosis and treatment of Coats\u2019 disease. Int Ophthalmol. 2019;39(4):957\u201370.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"4279_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/APO.0000000000000246","volume":"8","author":"CTL Khoo","year":"2019","unstructured":"Khoo CTL, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Udyaver S, et al. Factors predictive of subretinal fluid resolution in coats disease: analysis of 177 eyes in 177 patients at a single center. Asia Pac J Ophthalmol (Phila). 2019;8(4):290\u20137.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"4279_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/0301-4738.60081","volume":"58","author":"P Rishi","year":"2010","unstructured":"Rishi P, Rishi E, Uparkar M, Sharma T, Gopal L, Bhende P, et al. Coats\u2019 disease: an Indian perspective. Indian J Ophthalmol. 2010;58(2):119\u201324.","journal-title":"Indian J Ophthalmol"},{"key":"4279_CR17","doi-asserted-by":"crossref","unstructured":"Parlak M, Saat\u00e7i AO, eds. A review of intravitreal treatment alternatives used as an adjunctive therapy in coats' Disease2015.","DOI":"10.17554\/j.issn.2409-5680.2015.01.30"},{"issue":"7","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00417-011-1629-5","volume":"249","author":"MR B\u00f6hm","year":"2011","unstructured":"B\u00f6hm MR, Uhlig CE. Use of intravitreal triamcinolone and bevacizumab in Coats\u2019 disease with central macular edema. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):1099\u2013101.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"4279_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1167\/iovs.04-0905","volume":"46","author":"H Tamura","year":"2005","unstructured":"Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46(4):1440\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4279_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12886-020-01474-1","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Fan H, Gao K, He W, Tao Y. Levels of cytokines in the aqueous humor guided treatment of refractory macular edema in adult-onset coats\u2019 disease. BMC Ophthalmol. 2020;20(1):261.","journal-title":"BMC Ophthalmol"},{"key":"4279_CR21","unstructured":"Ucgul AY, \u00d6zdek \u015e. Coats' disease: a comprehensive review of its pathophysiology, diagnosis, and advances in treatment. Semin Ophthalmol. 2024:1\u201316."},{"issue":"3","key":"4279_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000355363","volume":"4","author":"AO Saatci","year":"2013","unstructured":"Saatci AO, Doruk HC, Yaman A. Intravitreal dexamethasone implant (ozurdex) in coats\u2019 disease. Case Rep Ophthalmol. 2013;4(3):122\u20138.","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"4279_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000492320","volume":"9","author":"AO Saatci","year":"2018","unstructured":"Saatci AO, Ayhan Z, Yaman A, Bora E, Ulgenalp A, Kavukcu S. A 12-year-old girl with bilateral coats disease and ABCA4 gene mutation. Case Rep Ophthalmol. 2018;9(2):375\u201380.","journal-title":"Case Rep Ophthalmol"},{"issue":"4","key":"4279_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000336906","volume":"227","author":"S Ghorbanian","year":"2012","unstructured":"Ghorbanian S, Jaulim A, Chatziralli IP. Diagnosis and treatment of coats\u2019 disease: a review of the literature. Ophthalmologica. 2012;227(4):175\u201382.","journal-title":"Ophthalmologica"},{"issue":"6","key":"4279_CR25","first-page":"336","volume":"13","author":"PR Egbert","year":"1976","unstructured":"Egbert PR, Chan CC, Winter FC. Flat preparations of the retinal vessels in Coats\u2019 disease. J Pediatr Ophthalmol. 1976;13(6):336\u20139.","journal-title":"J Pediatr Ophthalmol"},{"issue":"6","key":"4279_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000310735","volume":"210","author":"SM Steidl","year":"1996","unstructured":"Steidl SM, Hirose T, Sang D, Hartnett ME. Difficulties in excluding the diagnosis of retinoblastoma in cases of advanced Coats\u2019 disease: a clinicopathologic report. Ophthalmologica. 1996;210(6):336\u201340.","journal-title":"Ophthalmologica"},{"issue":"1","key":"4279_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1167\/iovs.12-10613","volume":"54","author":"S Kase","year":"2013","unstructured":"Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, et al. Expression of vascular endothelial growth factor in eyes with Coats\u2019 disease. Invest Ophthalmol Vis Sci. 2013;54(1):57\u201362.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4279_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/aos.13151","volume":"95","author":"J Feng","year":"2017","unstructured":"Feng J, Zheng X, Li B, Jiang Y. Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats\u2019 disease. Acta Ophthalmol. 2017;95(6):608\u201312.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"4279_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina. 2009;29(4):523\u20139.","journal-title":"Retina"},{"key":"4279_CR30","doi-asserted-by":"crossref","unstructured":"Banerjee M, Nayak S, Kashyap S, Bhayana A, Kumar V. Adult-onset Coats\u2019 disease. Survey Ophthalmol. 2023;68.","DOI":"10.1016\/j.survophthal.2023.03.002"},{"key":"4279_CR31","first-page":"251584142110559","volume":"13","author":"A Oli","year":"2021","unstructured":"Oli A, Balakrishnan D, Jalali S. Coats\u2019 disease: trends and long-term treatment outcomes in a tertiary referral centre. Ther Adv Ophthalmol. 2021;13:25158414211055956.","journal-title":"Ther Adv Ophthalmol"},{"issue":"3","key":"4279_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/bjophthalmol-2012-302250","volume":"97","author":"R Ray","year":"2013","unstructured":"Ray R, Bara\u00f1ano DE, Hubbard GB. Treatment of Coats\u2019 disease with intravitreal bevacizumab. Br J Ophthalmol. 2013;97(3):272.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4279_CR33","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1111\/aos.12158","volume":"92","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Peng XY, Chen FH, Zhang YP, Wang L, You QS, et al. Vascular endothelial growth factor in Coats\u2019 disease. Acta Ophthalmol. 2014;92(3):e225\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"4279_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10792-022-02451-x","volume":"43","author":"P Dorji","year":"2023","unstructured":"Dorji P, Raval V, Jalali S, Sahoo N, Padhi TR, Kaliki S, et al. Coats disease in India: clinical presentation and outcome in 675 patients (690 Eyes). Int Ophthalmol. 2023;43(2):531\u201340.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"4279_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/bjophthalmol-2011-300141","volume":"96","author":"A Ramasubramanian","year":"2012","unstructured":"Ramasubramanian A, Shields CL. Bevacizumab for Coats\u2019 disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol. 2012;96(3):356\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4279_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/bjophthalmol-2012-302250","volume":"97","author":"R Ray","year":"2013","unstructured":"Ray R, Bara\u00f1ano DE, Hubbard GB. Treatment of Coats\u2019 disease with intravitreal bevacizumab. Br J Ophthalmol. 2013;97(3):272\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4279_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3341\/kjo.2008.22.3.190","volume":"22","author":"JH Jun","year":"2008","unstructured":"Jun JH, Kim YC, Kim KS. Resolution of severe macular edema in adult coats\u2019 disease with intravitreal triamcinolone and bevacizumab injection. Korean J Ophthalmol. 2008;22(3):190\u20133.","journal-title":"Korean J Ophthalmol"},{"key":"4279_CR38","doi-asserted-by":"publisher","first-page":"9131908","DOI":"10.1155\/2020\/9131908","volume":"2020","author":"Q Chen","year":"2020","unstructured":"Chen Q, Liang S, Wang X, Hu C, She J, Li Z. Efficacy and safety outcomes of intravitreal dexamethasone implant therapy for the treatment of adult coats\u2019 disease. J Ophthalmol. 2020;2020:9131908.","journal-title":"J Ophthalmol"},{"issue":"1","key":"4279_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000337481","volume":"3","author":"S Martinez-Castillo","year":"2012","unstructured":"Martinez-Castillo S, Gallego-Pinazo R, Dolz-Marco R, Marin-Lambies C, Diaz-Llopis M. Adult coats\u2019 disease successfully managed with the dexamethasone intravitreal implant (ozurdex(R)) combined with retinal photocoagulation. Case Rep Ophthalmol. 2012;3(1):123\u20137.","journal-title":"Case Rep Ophthalmol"},{"key":"4279_CR40","doi-asserted-by":"crossref","unstructured":"Chen Q, Liang S, Wang X, Hu C, She J, Li Z. Efficacy and safety outcomes of intravitreal dexamethasone implant therapy for the treatment of adult coats' disease. J Ophthalmol. 2020;2020.","DOI":"10.1155\/2020\/9131908"},{"issue":"1","key":"4279_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000337481","volume":"3","author":"S Mart\u00ednez-Castillo","year":"2012","unstructured":"Mart\u00ednez-Castillo S, Gallego-Pinazo R, Dolz-Marco R, Mar\u00edn-Lamb\u00edes C, D\u00edaz-Llopis M. Adult coats\u2019 disease successfully managed with the dexamethasone intravitreal implant (ozurdex\u00ae) combined with retinal photocoagulation. Case Rep Ophthalmol. 2012;3(1):123\u20137.","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"4279_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10792-018-0827-0","volume":"39","author":"K Kumar","year":"2019","unstructured":"Kumar K, Raj P, Chandnani N, Agarwal A. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats\u2019 disease. Int Ophthalmol. 2019;39(2):465\u201370.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"4279_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jcjo.2015.01.007","volume":"50","author":"S Lei","year":"2015","unstructured":"Lei S, Lam WC. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children. Can J Ophthalmol. 2015;50(3):236\u201341.","journal-title":"Can J Ophthalmol"},{"issue":"20","key":"4279_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020249","volume":"99","author":"YH Ding","year":"2020","unstructured":"Ding YH, Yao BT, Zhao XG, Yu H, Liu G, Wang XY. Refractory adult Coats disease treated with dexamethasone intravitreal implant: a case report. Med (Baltimore). 2020;99(20): e20249.","journal-title":"Med (Baltimore)"},{"issue":"4","key":"4279_CR45","first-page":"380","volume":"86","author":"AM Dorado","year":"2023","unstructured":"Dorado AM, De-Pablo-Cabrera A, Mu\u00f1oz-Gallego A, Moreno-Garc\u00eda L, Barcel\u00f3-Mendiguch\u00eda A. Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats\u2019 disease. Arq Bras Oftalmol. 2023;86(4):380\u20133.","journal-title":"Arq Bras Oftalmol"},{"key":"4279_CR46","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez NC, Villegas VM, Berrocal AM, Gold AS, Latiff A, Murray TG. Targeted multimodality treatment to eliminate the need for enucleation in advanced coats disease. J Vitreoretin Dis. 2024:24741264241301812.","DOI":"10.1177\/24741264241301812"},{"issue":"11","key":"4279_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3928\/23258160-20240621-03","volume":"55","author":"KG Patel","year":"2024","unstructured":"Patel KG, Abbey AM. Injectable fluocinolone implant for the management of cystoid macular Edema in Coats\u2019 disease. Ophthalmic Surg Lasers Imaging Retina. 2024;55(11):679\u201381.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04279-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:02:06Z","timestamp":1757322126000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04279-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04279-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Dokuz Eylul University Training and Research Hospital (Approval No: 2025\/05\u201324, Date: 12.02.2025). This study was retrospective in nature and based solely on pre-existing medical records. As such, no direct contact with patients occurred. In accordance with the decision of the ethics committee, informed consent was not required for this type of retrospective chart review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}